Skip to main content
. 2021 Oct 21;12:741059. doi: 10.3389/fpsyt.2021.741059

Table 1.

Characteristics of the included studies.

Study Setting Country Ethnicity Sample size (M:F) Dementia type Dementia diagnosis Dementia severity Mean age (yr) Disease duration Assessment of BPSD Assessed by
Forsell and Winblad (17) CS Sweden NR 1,101 including 306 dementia patients (46:260) NR DSM-III-R MMSE:
-Without depression: 14.6
-With depression: 12.2
Without depression: 86.5
With depression: 87.6
NR 1. DSM-IV (major depression)
2. Comprehensive Psychopathological Rating Scale
Physicians
Klein et al. (18) CS US Multiethnicity (White, etc.) 638 (212:426) AD: 345 VD: 99 Other: 194 DSM-IV MMSE: 16.6 ± 7.2 75.2 ± 10.2 4.0 ± 3.0 yr 1. Wandering behavior in the past 2 weeks
2. DSM-IV glossary definitions. (delusions, hallucinations)
3. DSM-IV criteria (sleep disorders)
4. CSDD (depression)
Clinicians by interviewing the patient and caregiver
Teri et al. (19) CS US Multiethnicity (Caucasian, etc.) 523 (raw data was not presented for sex ratio) AD NINCDS-ADRDA criteria MMSE: 20.4 ± 4.9 73.6 ± 6.9 NR 1.21-item behavior checklist (anxiety, depression, other problematic behaviors: present or absent) Physician by observation of patient and informant
Bassiony et al. (20) CS US Multiethnicity (Caucasian, African-American, Hispanic) 342 (82:260) AD NINCDS/
ADRDA criteria
MMSE: 14.7 ± 7.1 77.2 ± 9.1 4.5 ± 3.0 yr 1. DSM-IV (psychotic symptoms in the past 2 weeks) Experienced geriatric psychiatrists using input from family members, caregivers and primary care physicians
Lyketsos et al. (21) CS US NR 1,002 including 329 dementia patients (123:206) AD: 214 VD: 62 Other: 53 DSM-IV CDR 0.5, 1.0, 2, 3–5 84.2 ± 7.0 NR 1. NPI Trained psychometrician or nurse
Lyketsos et al. (22) LS US Multiethnicity (White and Black) 842 including 362 dementia patients (132:230) AD: 258 VD: 86 PD: 6 Other: 12 DSM-IV, NINCDS/
ADRDA criteria
NR 77 ± 5.0 NR 1. NPI Researchers by fully structured interview of informant
Arbus et al. (23) CS France NR 578 AD NR Reisberg classification 2 or 3, 4, 5 or 6 NR NR 1. NPI NR
Rolland et al. (24) CS France NR 571 AD NR MMSE: 10-29 Without wandering: 77.4 ± 7.1
With wandering: 77.6 ± 6.7
Without wandering: 1.1 ± 1.2 yr With wandering: 1.2 ± 1.2 yr 1. NPI Based on a structured interview with a caregiver
Xie et al. (25) CS China Chinese 1,540 including 373 dementia patients (223:150) NR DSM-IV CDR 1 or 2 79.9 ± 9.8 NR 1. NPI NR
Benoit et al. (26) LS France NR 482 (140:342) AD DSM-IV, NINCDS/
ADRDA criteria
MMSE
-Mild group: 23.5 ± 1.7
-Moderate group: 16.9 ± 2.6
Mild group: 77.2 ± 6.0
Moderate group:77.3 ± 7.8
Mild group: 38.9 ± 26.9 mon Moderate group: 47.4 ± 32.6 mon 1. NPI Based on a structured interview with a caregiver
Wilson et al. (27) LS US Multiethnicity (African American, etc.) 407 (134:273) AD NINCDS/
ADRDA criteria
MMSE
-With hallucinations: 17.4 ± 4.1
-Without hallucinations: 19.7 ± 4.3
With hallucinations: 76.7 ± 6.6
Without hallucinations: 74.5 ± 7.7
NR 1. Questionnaire (hallucinations, delusions) A structured interview administered by a trained research assistant
Peters et al. (28) CS Canada NR 804 including 576 dementia patients (252:324) NR DSM-III MMSE: 20.7 ± 5.6 73.0 ± 8.5 NR 1. NPI NR
Rolland et al. (29) LS France NR 682 AD NINCDS/
ADRDA criteria
MMSE: 20.1 ± 4.5 77.4 ± 7 NR 1. NPI NR
Benoit et al. (30) CS France NR 686 AD ICD-10, NINCDS/
ADRDA
MMSE: 20.0 ± 4.23
CDR 0.5, 1, 2, 3
77.9 ± 6.8 No apathy, no depression: 13.42 ± 13.09 mon
Only depression: 8.92 ± 9.41 mon
Only apathy: 13.51 ± 14.06 mon
Both apathy and depression: 14.09 ± 14.82 mon
1. NPI NR
Orengo et al. (31) RS US Multiethnicity (African American, Hispanic, Caucasian, etc.) 385 (383:2) AD: 82 VD: 70 Other: 226 ICD-9-CM NR NR NR 1. RAS Administered during a telephone screen (research staff)
Steinberg et al. (32) LS US NR 408 AD: 255 VD: 44 Mixed: 27 Other: 82 Diagnosed in CCSMHA (DSM–III–R, NINCDS/
ADRDA)
CDR 0.5–1, 2, 3–5 NR NR 1. NPI Trained examiner, through a structured interview with the caregiver
Rao et al. (33) LS US NR 449 (166:283) AD: 271 AD + VD: 31 AD + other: 16 VD: 50 Other: 81 DSM-III-R
NINCDS-ADRDA, NINDS-AIREN
MMSE
-With TBI: 21.8 ± 5.9
-Without TBI: 21.3 ± 5.5
With TBI: 84.54 ± 5.3
Without TBI: 85.1 ± 6.5
MMSE
-With TBI: 1.8 ± 1.4 yr
-Without TBI: 1.9 ± 1.3 yr
1. NPI Administered to caregivers or to persons very familiar with the participants
Spalletta et al. (34) CS Italy NR 1,015 (292:723) AD NINCDS/
ADRDA
MMSE: 2.7 ± 0.1 74.6 ± 0.2 2.7 ± 0.1 yr 1. NPI (10-item) An informant rated.
Arbus et al. (35) LS France NR 686 (198:488) AD DSM-IV, NINCDS/
ADRDA
MMSE
-No depression nor antidepressants at baseline: 20.43 ± 4.09
-Depression and/
or antidepressants at baseline: 19.65 ± 4.33
No depression nor antidepressants at baseline: 77.71 ± 7.03
Depression and/
or antidepressants at baseline: 77.99 ± 6.67
No depression nor antidepressants at baseline: 13.62 ± 13.40 mon Depression and/
or antidepressants at baseline: 12.73 ± 13.38 mon
1. NPI Are read to the caregiver
Rountree et al. (36) LS US Multiethnicity (White, etc.) 641 (205:436) AD NINCDS/
ADRDA
MMSE: 19.5 ± 6.64 73.0 ± 8.50 3.7 ± 2.29 yr 1. Questionnaire (hallucinations, delusions) NR
Haibo et al. (37) CS China NR 1,271 NR DSM-IV MMSE: 16.5 ± 6.3 80.9 ± 6.3 NR 1. NPI Neuropsychiatrist
Andreasen et al. (38) CS Peru, Mexico, Venezuela, Puerto Rico, Cuba, India, China and Dominican Republic NR 17,031 including 1,612 dementia patients (359:1,251) AD: 424 VD: 244 DLB: 55 Unspecified: 889 DSM-IV
10/66 algorithm
NR NR NR 1. GMS-AGECAT Employed researcher
Sadak et al. (39) CS US Multiethnicity (White, Black, Hispanic, etc.) 3,768 (1,647:2,121) AD: 3,338 DLB: 241 Behavioral variant FTD: 189 NINCDS-ADRDA (AD), Third report of the DLB Consortium (DLB), Consensus (behavioral variant FTD), NINDS-AIREN (VD) CDR 1, 2, 3+ 79 ± 6.98 NR 1. NPI-Q Patient and family caregiver self-reports, review of medical records, and clinical evaluations
Wergeland et al. (40) CS Norway NR 1,000 including 415 dementia patients (273:142) NR ICD-10 NR NR NR 1. NPI (10-item) Physicians
Mograbi et al. (41) CS Latin America, China, India NR 829 NR DSM-IV, 10/
66 criteria
CDR 0.5, 1, 2/
3
NR NR 1. NPI
2. ICD (depression)
Interview made with an informant
Vaingankar et al. (42) CS Singapore Multiethnicity (Chinese, Malay, Indian) 399 (124:275) Dementia Semi-structured GMS-AGECAT along with CSI-D, CERAD test battery, and HAS-DDS, and also by applying the
10/66 protocol's diagnostic criteria
CDR: 2.2 ± 0.6 80.2 ± 0.3 NR 1. NPI Trained lay interviewers to the older adults' informant
Connors et al. (43) LS Australia NR 445 (222:223) AD DSM-IV MMSE: 21.1 ± 5.3 78.7 ± 7.3 1.6 ± 1.9 yr 1. NPI (12-item) A research nurse/
psychologist or specialist clinician
Costa et al. (44) CS European (England, Estonia, Finland, France, Germany, Netherlands, Spain, Sweden) NR 1,997 including 1,217 community patients AD, VD, Other (raw data was not presented) Diagnosed by expert assessment (i.e, psychiatrist, neurologist, geriatrician, or general practitioner depending on countries' specific diagnostic procedures) and recorded in the medical record, MMSE score of 24 or below, and the presence of an informal caregiver (who visits at least twice a month) NR Agitation (+): 82.02 ± 0.22
Agitation (–): 82.88 ± 0.36
NR 1. NPI As a structured interview with a knowledgeable informant
Lessing et al. (45) Baseline data from two clinical trials US Multiethnicity (White, African-American, etc.) 509 Dementia Physician diagnosis of dementia or MMSE scores of 23 or less NR 82.6 ± 8.5 NR 1. ABID (aggression, agitation, rejection) Caregiver-based rating
Holmstrand et al. (46) LS European (Finland, France, Germany, Netherlands, Spain, etc.) NR 1,163 (431:732) AD: 629 AD+VD: 71 VD: 186 FTD: 6 DLB: 23 Not specified: 185 Other: 54 NR MMSE: median 15 With suicidal ideation: median 82
Without suicidal ideation: median 83
NR 1. NPI-Q
2. CSDD
Professionals in health or social care or by medical/
nursing/
social care students with practical experience and at least a Bachelor's degree

ABID, Agitated Behavior in Dementia Scale; AD, Alzheimer's disease; BPSD, behavioral and psychological symptoms of dementia; CCSMHA, Cache County Study of Memory Health and Aging; CDR, clinical dementia rating; CERAD, Consortium to Establish a Registry for Alzheimer's Disease; CS, cross-sectional study; CSDD, Cornell Scale for Depression in Dementia; CSI-D, Community Screening Interview for Dementia; DLB, dementia with Lewy bodies; DSM, Diagnostic and Statistical Manual of Mental Disorders; FTD, frontotemporal dementia; GMS-AGECAT, Geriatric Mental State-Automated Geriatric Examination for Computer Assisted Taxonomy; HAS-DDS, History and Etiology Schedule–Dementia Diagnosis and Subtype; ICD, International Classification of Diseases; LS, longitudinal study; MMSE, Mini-Mental State Examination; NINCDS/ADRDA, National of Neurological Communicative Disease and Stroke and the Alzheimer's Disease and Related Disorders; NPI, neuropsychiatric inventory; NPI-Q, neuropsychiatric inventory-questionnaire; NR, nor recorded; PD, dementia due to Parkinson's disease; RAS, Ryden Aggression Scale; RS, retrospective study; US, United States; VD, vascular dementia.

CDR 0 = absent; 0.5 = questionable; 1 = present, but mild; 2 = moderate; 3 = severe; 4 = profound; and 5 = terminal.